Zoetis
June 16, 2025
Company Presentation
Pain Management
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detect, and treat animal illness for more than 70 years, Zoetis continues to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers and ranchers. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. A Fortune 500 company, Zoetis generated revenue of $8.5 billion in 2023 with approximately 14,100 employees.
Company HQ City:
Parsippany
Company HQ State:
NJ
Company HQ Country:
United States
Year Founded:
2013
Lead Product in Development:
We don't disclose products in development.
Key On-Market Products - Simparica Trio, Apoquel, Cytopoint, Librela, Solensia, and so on
CEO
Kristin Peck (CEO)
Year Founded
2013
Development Phase of Lead Product
Multiple Products in Market
Exchange
New York Exchange
Ticker
ZTS
When you expect your next catalyst update?
Not applicable
What is your next catalyst (value inflection) update?
Not applicable
Website
www.zoetis.com
Primary Speaker
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}